Kimberly Feliciano-Rodriguez
Family · Weston, FLNPI 1174138796
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by UCB, Inc. at 32.2% of the total. 2025 is the largest year on record at $2,641, more than ten times the $55 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- Neurelis, Inc.$1K
- Jazz Pharmaceuticals Inc.$984
- Novo Nordisk$413
- Catalyst Pharmaceuticals, Inc.$317
- Corium, LLC$280
- plus $2K from 24 others
What the payments were for
- Food & beverage$7,208100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 80 | $2,328 |
| Neurelis, Inc. | 40 | $1,209 |
| Jazz Pharmaceuticals Inc. | 41 | $984 |
| Novo Nordisk | 5 | $413 |
| Catalyst Pharmaceuticals, Inc. | 16 | $317 |
| Corium, LLC | 13 | $280 |
| Supernus Pharmaceuticals, Inc. | 3 | $276 |
| Collegium Pharmaceutical, Inc. | 12 | $215 |
| Sumitomo Pharma America, Inc. | 7 | $143 |
| Boston Scientific | 5 | $128 |
| Immedica Pharma US, Inc. | 4 | $102 |
| Bayer | 5 | $84 |
| Aucta Pharmaceuticals, Inc. | 3 | $78 |
| Otter Pharmaceuticals, LLC | 3 | $77 |
| Aquestive Therapeutics, Inc. | 3 | $65 |
| Johnson & Johnson | 3 | $65 |
| Acadia Pharmaceuticals Inc | 3 | $64 |
| Novartis | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| AbbVie | 2 | $52 |
| Tris Pharma Inc | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| SK Life Science, Inc. | 1 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Metacel Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,234 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Other family in Weston
- Clara DelgadoWeston$31K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.